Date/Time
Date(s) - 28 Jan 2025
8:00 AM - 9:00 AM
In this session, our panelists will share key insights from the 2025 JP Morgan Healthcare Conference, with a focus on what early-stage life science companies need to know to thrive in the current landscape. Topics will include investment trends, fundraising strategies, and how to position your company to attract interest from VCs and strategic partners. The panel will also cover emerging areas of innovation, potential regulatory changes, and how early-stage companies can leverage partnerships to accelerate growth. This discussion is designed to provide actionable takeaways to help you navigate the challenges and opportunities ahead in 2025 and beyond.
Register Here
Panelists:
Pierre-Alexandre Fournier
A Hands-On, global executive with success in sales, marketing & P&L leadership in the pharmaceutical/medical device and biotech industries. Proven record of accelerating sales and enhancing profitability, building commercial organizations, negotiating global alliances, leading drug and diagnostic launches and raising capital for both private and public biotech companies.
Navin Govind
Navin Govind is a serial entrepreneur, investor, experienced C-level executive with several years of proven success at Intel Corporation, Tarari and Aventyn, Inc., developing winning global strategies for the adoption of new technology, architecture and products within the digital health, applications and secure content provider industries. Navin was founding team member at Tarari, managed the industry’s first hardware XML Content Processor product developed for
enterprises to secure and accelerate content processing applications from concept to launch. Tarari was acquired by LSI Corporation for $85M in September 2007. At Intel Corporation, he held wireless group level ($5B P&L) and business unit level platform marketing positions, managed technical teams within Intel Labs responsible for wireless architecture, software development, 3D graphics, embedded products and development tools with a strong focus on life changing mobile platforms.
He currently serves as founder and CEO of global award winning, innovative digital therapeutic companies with clinically validated virtual care cloud solutions connecting clinicians and patients for improved quality of life, CGO at 8chili a GPEC/ACA partner company in Phoenix, AZ innovating health metaverse with Virtual Reality, AI, Crypto and Blockchain. He is venture partner at Evidence Ventures, angel investor, author of several original papers in peer reviewed journals and holds multiple issued patents. Navin is a frequent speaker and industry faculty for health technology innovation, startup advisory, health policy for digital health standards initiatives at TIA, HIMSS, IEEE and ETSI. He is the founder and executive chair of the b-eCare Connected Health Initiative sponsoring unique international, multi-center clinical evidence studies for improved chronic disease management.